Literature DB >> 10445561

Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?

A Sonnenberg1, F Delcò, P Bauerfeind.   

Abstract

OBJECTIVE: Computed tomography (CT) or magnetic resonance (MR) colonography is a new technique that uses data generated from CT or MR imaging to create two- and three-dimensional scans of the colon. It has been advocated to become the new primary technique of screening for colorectal cancer. The economic feasibility of such recommendation, however, has not yet been evaluated.
METHODS: The cost-effectiveness of two screening strategies using CT colonography or conventional colonoscopy was compared by computer models based on a Markov process. We supposed that a hypothetical population of 100,000 subjects aged 50 yr undergoes a screening procedure every 10 yr. Suspicious findings of CT colonography are worked-up by colonoscopy. After polypectomy, colonoscopy is repeated every 3 yr until no adenomatous polyps are found.
RESULTS: Under baseline conditions, screening by CT colonography costs $24,586 per life-year saved, compared with $20,930 spent on colonoscopy screening. The incremental cost-effectiveness ratios comparing CT colonography to no screening and colonoscopy to CT colonography were $11,484 and $10,408, respectively. Screening by colonoscopy remains more cost-effective even if the sensitivity and specificity of CT colonography both rise to 100%. For the two screening procedures to become similarly cost-effective, CT colonoscopy needs to be associated with an initial compliance rate 15-20% better or procedural costs 54% less than colonoscopy.
CONCLUSIONS: To become cost-effective and be able to compete with colonoscopy in screening for colorectal cancer, CT or MR colonography would need be offered at a very low price or result in compliance rates much better than those associated with colonoscopy.

Entities:  

Mesh:

Year:  1999        PMID: 10445561     DOI: 10.1111/j.1572-0241.1999.01304.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

Review 1.  Trends in CT colonography.

Authors:  J F Bruzzi; D D Brennan; H M Fenlon
Journal:  Curr Gastroenterol Rep       Date:  2001-10

Review 2.  The diagnostic and therapeutic roles of colonoscopy: a review.

Authors:  E H Huang; J M Marks
Journal:  Surg Endosc       Date:  2001-12       Impact factor: 4.584

Review 3.  CT screening: a trade-off of risks, benefits, and costs.

Authors:  M G Myriam Hunink; G Scott Gazelle
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  The virtuosity of virtuality or how real is virtual colonography.

Authors:  H Herfarth; A G Schreyer
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 5.  Virtual endoscopy: current perspectives.

Authors:  Hajime Kuwayama; Mamoru Iimuro; Yoshinori Kitazumi; Gordon Luk
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

6.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

7.  Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.

Authors:  Steven J Heitman; Braden J Manns; Robert J Hilsden; Andrew Fong; Stafford Dean; Joseph Romagnuolo
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

Review 8.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

Review 9.  Current status of CT colonography.

Authors:  Suzanne M Frentz; Ronald M Summers
Journal:  Acad Radiol       Date:  2006-12       Impact factor: 3.173

Review 10.  CT colonography for population screening: ready for prime time?

Authors:  Perry J Pickhardt
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.